Work

A Neoadjuvant Chemotherapy Trial for Early Breast Cancer is Impacted by COVID-19: Addressing Vaccination and Cancer Trials Through Education, Equity, and Outcomes

Year: 2021

Type: article

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-21-1133

Authors: David A. Potter, Alexandra Thomas, Hope S. Rugo

Institutions: University of Minnesota, Masonic Cancer Center, Wake Forest Baptist Comprehensive Cancer Center, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center

Language: English

Topic: COVID-19 and healthcare impacts

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

Funders: Safeway Foundation, Foundation for the National Institutes of Health, William K. Bowes, Jr. Foundation, Center for Biomedical Informatics and Information Technology, National Cancer Institute

Award: G8513382882

OpenAlex ID: W3171736503

FWCI: 0.637

Cites: 47

Cited by: 9

Related to: 10